Literature DB >> 19779780

Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.

Takaaki Fujii1, Toshihiro Nakabayashi, Shinji Hashimoto, Hiroyuki Kuwano.   

Abstract

Parkinson's disease is a chronic progressive disease with symptoms of tremors, rigidity, and akinesia. Parkinson's disease is a major risk factor for postoperative complications and it is difficult to manage patients with Parkinson's disease after gastrointestinal surgery. This report presents the cases of three patients with Parkinson's disease who underwent gastrointestinal surgery and had no serious postoperative complications. Antiparkinsonian medications were reduced before surgery and replaced by an intravenous infusion of levodopa until the patients could take oral antiparkinson drugs after surgery to prevent malignant syndrome or exacerbate parkinsonism. Prokinetics were also used for the prevention of paralytic ileus. These cases demonstrate an effective method to administer antiparkinson drugs during perioperative management of patients with Parkinson's disease and also indicate that sufficient doses of antiparkinson drugs can control the symptoms of parkinsonism and prevent complications in cases of surgery with parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779780     DOI: 10.1007/s00595-008-3938-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Postoperative complications in Parkinson's disease.

Authors:  P V Pepper; M K Goldstein
Journal:  J Am Geriatr Soc       Date:  1999-08       Impact factor: 5.562

2.  Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia.

Authors:  R Furuya; A Hirai; T Andoh; I Kudoh; F Okumura
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

3.  Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease.

Authors:  M Contin; R Riva; P Martinelli; P Cortelli; F Albani; A Baruzzi
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

4.  Characterization of swallowing and defecation in Parkinson's disease.

Authors:  L L Edwards; E M Quigley; R K Harned; R Hofman; R F Pfeiffer
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Parkinson syndrome. A significant risk factor in the patient with acute surgical disorder.

Authors:  D Simon; O M Shapira; E Mor; R Pfefferman
Journal:  Int Surg       Date:  1992 Oct-Dec

Review 7.  Gastrointestinal motility after digestive surgery.

Authors:  Erito Mochiki; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

8.  Parkinsonism with 'on-off' phenomena. Intravenous treatment with levodopa after major abdominal surgery.

Authors:  A J Rosin; D Devereux; N Eng; D B Calne
Journal:  Arch Neurol       Date:  1979-01

9.  Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease.

Authors:  G N Ali; K L Wallace; R Schwartz; D J DeCarle; A S Zagami; I J Cook
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Authors:  C Singaram; W Ashraf; E A Gaumnitz; C Torbey; A Sengupta; R Pfeiffer; E M Quigley
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

View more
  2 in total

1.  Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease.

Authors:  Young Eun Kim; Han-Joon Kim; Ji Young Yun; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-06       Impact factor: 4.849

Review 2.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.